Protalix Signs $280m Agreement With Brazilian Health Agency for Supply of Gaucher Disease Medication

The seven-year agreement could make Protalix and Pfizer, it's partner in international commercialization, the largest suppliers of Gaucher medication in Brazil.

Yoram Gabison
Yoram Gabison
Send in e-mailSend in e-mail

Comments